Résultats de la recherche - 23 results
Fluoroquinolone resistance in Escherichia coli isolates after exposure to non-fluoroquinolone antibiotics: a retrospective case–control study
tertiary care patients in Belgium with information on prior antibiotic use at the patient level up to 1 year previously. Results In urine samples from 6125 patients, 7204 E. coli isolates were retrieved ...
Genomic epidemiology of emerging ESBL-producing Kentucky in Europe.
this clone. We dated the origin of the clone to approximately 2005 in Northern Africa, most likely in Egypt. The geographic origin predicted by the phylogenetic analysis is consistent with the patients ...
Molecular surveillance of anti-malarial drug resistance in Democratic Republic of Congo: high variability of chloroquinoresistance and lack of amodiaquinoresistance.
the presence of the SVMNT haplotype. METHODS: In 2017, ten geographical sites across the DRC were selected. Dried blood samples were collected from patients attending health centres. Malaria was first ...
Superficial mycoses in Belgium: Burden, costs and antifungal drugs consumption
practitioners while consumption varied according to age and gender of the patients. A global 12% decrease in antifungal prescriptions was observed between 2011 and 2017. However, this reduction would result ...
Prevalence of healthcare-associated infections, estimated incidence and composite antimicrobial resistance index in acute care hospitals and long-term care facilities: results from two European point prevalence surveys, 2016 to 2017
healthcare-associated infections (HAI) and antimicrobial use in the European Union and European Economic Area (EU / EEA) from 2016 to 2017 included 310,755 patients from 1,209 acute care hospitals (ACH) in 28 countries ...
Antimicrobial use in European acute care hospitals: results from the second point prevalence survey (PPS) of healthcare-associated infections and antimicrobial use, 2016 to 2017
hospitals. We included 1,209 hospitals and 310,755 patients in 28 of 31 European Union/European Economic Area (EU / EEA) countries. The weighted prevalence of antimicrobial use in the EU / EEA was 30.5% (95% ...
Time trend of prevalence and susceptibility to nitrofurantoin of urinary MDR Escherichia coli from outpatients
nitrofurantoin was compared between 2005 and 2011-12 using a generalized estimating equation model. Results: MDR status could be determined for 9704 and 12512 urinary E. coli isolates from 7911 and 9441 patients ...
Point Prevalence Study of Healthcare-Associated Infections and Antimicrobial Use in Belgian Acute-Care Hospitals: Results of the ECDC PPS 2017
(ECDC). In the participating Belgian acute care hospital sites (N=52, September-December 2011), the prevalence of patients with at least one antimicrobial and at least one HAI was 28.9% (95% confidence ...
Surveillance of antimicrobial resistant bacteria in Belgian hospitals: Report 2016
(with de-duplication) were included in the analyses, i.e. per period of hospitalisation and bacterium each patient should only be counted once. Clinical samples and screening samples originating from ...
Characteristics of the antibiotic regimen that affect antimicrobial resistance in urinary pathogens
with lower probabilities of AMR, provided that the number of preceding prescriptions is not extremely high (≥10 during the 1.5 year observation period; 93% of 5650 included patients). Health Topics: ...